Valuation: Sugentech Inc.

Market Cap 63.83B 45.16M 39M 36.65M 33.33M 62.67M 4.32B 63.7M 429M 168M 2.16B 170M 166M 7.19B P/E 2024
-5.35x
P/E 2025 -4.03x
Enterprise Value 33.63B 23.79M 20.55M 19.31M 17.56M 33.02M 2.28B 33.56M 226M 88.47M 1.14B 89.33M 87.39M 3.79B EV / Sales 2024
3.27x
EV / Sales 2025 6.76x
Free-Float
76.84%
Yield 2024 *
-
Yield 2025 -
1 day-0.83%
1 week-6.81%
Current month+9.87%
1 month+10.01%
3 months-39.93%
6 months-31.78%
Current year-32.00%
1 week 4,100
Extreme 4100
4,720
1 month 3,530
Extreme 3530
4,720
Current year 3,530
Extreme 3530
8,170
1 year 3,530
Extreme 3530
8,250
3 years 3,530
Extreme 3530
11,500
5 years 3,530
Extreme 3530
23,750
10 years 3,530
Extreme 3530
65,800
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 25/09/2017
Chief Executive Officer 61 25/09/2017
Director of Finance/CFO 56 30/03/2022
Director TitleAgeSince
Director/Board Member 61 25/09/2017
Director/Board Member 59 25/09/2017
Director/Board Member 50 30/03/2022
Date Insider Type Main position Quantity % Market Cap.
02/04/24 Others 18,730 0.1120%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-6.81%-44.26%-42.25% 45.16M
+1.02%+2.28%+20.56%-35.06% 17.1B
-2.98%+0.45%-7.31%+95.48% 1.76B
-0.44%-2.23%-27.52%+19.28% 985M
-5.24%+16.40%-44.89%-81.27% 981M
-0.05%+48.99%+71.52%-10.59% 779M
+0.95%+2.45%-35.49%-49.59% 696M
+3.92%+17.79%-34.13%-41.23% 646M
+5.89%+6.05%-40.58%-38.02% 443M
-0.99%+12.73%+41.58%+41.18% 414M
Average +0.12%+8.19%-10.05%-14.21% 2.39B
Weighted average by Cap. +0.50%+4.19%+11.48%-23.61%

Financials

2024 2025
Net sales 10.1B 7.14M 6.17M 5.8M 5.27M 9.91M 683M 10.08M 67.93M 26.56M 342M 26.82M 26.24M 1.14B 9.42B 6.66M 5.75M 5.41M 4.92M 9.24M 637M 9.4M 63.35M 24.77M 319M 25.01M 24.47M 1.06B
Net income -15.19B -10.75M -9.28M -8.72M -7.93M -14.92M -1.03B -15.16M -102M -39.96M -515M -40.35M -39.48M -1.71B -23.31B -16.49M -14.25M -13.39M -12.17M -22.89M -1.58B -23.27M -157M -61.33M -790M -61.93M -60.58M -2.62B
Net Debt -48.51B -34.31M -29.64M -27.85M -25.33M -47.62M -3.28B -48.4M -326M -128M -1.64B -129M -126M -5.46B -30.2B -21.37M -18.45M -17.34M -15.77M -29.65M -2.04B -30.14M -203M -79.44M -1.02B -80.22M -78.48M -3.4B
Logo Sugentech Inc.
Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.
Employees
144
Date Price Change Volume
14/08/26 ₩4,175.00 -0.83% 93,186
13/08/26 ₩4,210.00 -5.50% 123,280
12/08/26 ₩4,455.00 -3.68% 71,962
11/08/26 ₩4,625.00 +0.54% 103,448
10/08/26 ₩4,600.00 +2.68% 191,200
  1. Stock Market
  2. Stocks
  3. A253840 Stock